Global Information
회사소개 | 문의 | 위시리스트

세계의 인공눈물 시장

Artificial Tears

리서치사 Global Industry Analysts, Inc.
발행일 2019년 05월 상품 코드 248932
페이지 정보 영문 143 Pages
가격
US $ 5,450 ₩ 6,650,000 PDF by E-mail (Single User License) help
DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로 1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste 가 되지 않으며, 인쇄는 1회에 한해 가능합니다. 인쇄물 이용은 PDF 라이선스 소유자로 한정됩니다.
US $ 16,350 ₩ 19,950,000 PDF by E-mail (Global License to Company and its Fully-owned Subsidiaries) help
동일 기업 및 100% 자회사의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수 제한은 없습니다. PDF 파일은 Copy & Paste 가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.

주의 : 본 보고서는 DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로, 라이선스에 따라 자료 이용 및 인쇄 등에 제약이 있을 수 있습니다. 자세한 내용은 라이선스 설명문( )을 참고하여 주시기 바랍니다.



세계의 인공눈물 시장 Artificial Tears
발행일 : 2019년 05월 페이지 정보 : 영문 143 Pages

세계의 인공눈물(Artificial Tears) 시장을 조사했으며, 시장 현황과 향후 성장 예측, 지역별 동향, 시장 진출기업 개요 등의 정보를 정리하여 전해드립니다.

제1장 서론, 조사 방법, 제품 정의

제2장 업계 개요

  • 안구건조증
  • 인공눈물
  • 기타 안구건조증 치료
  • 현재 및 향후 분석
  • 개발도상국이 강력한 성장 전망
  • 안구건조증 이환율과 발병률
  • 안구건조증의 다양한 성질이 약제 제조업체의 과제
  • 고령화
  • 시장이 해결해야 할 과제
  • 명확한 제품 차별화 결여
  • 낮은 환자 적합성이 시장 기회를 제한

제3장 특필해야 할 시장 동향

제4장 안구건조증 : 개요

  • 일반적 안과 증상
  • 원인
  • 진단
  • 안구건조증의 다양한 성질이 약제 제조업체의 공헌을 저해
  • 안구건조증 진단과 치료 등

제5장 제품 개요

  • 개요
  • 인공눈물의 종류
  • 사용과 용량
  • 인공눈물의 전개
  • 제1세대
  • 제2세대
  • 제3세대
  • 제4세대
  • 대체치료법

제6장 경쟁 환경

  • 주요 기업
  • 1회 사용
  • 다회 사용
  • 제품 출시/인가/도입
  • 최근의 업계 활동

제7장 세계 시장 전망

제8장 지역별 시장 동향

  • 미국
  • 캐나다
  • 일본
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 기타 국가

제9장 기업 개요

LSH 18.08.28

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

This report analyzes the worldwide markets for Artificial Tears in US$ Thousand. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 49 companies including many key and niche players such as -

Allergan, Inc.
Akorn, Inc.
Bausch & Lomb Incorporated
Johnson & Johnson
Novartis International AG
Santen Pharmaceuticals Co, Ltd.

Table of Contents

1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
  • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study

2. INDUSTRY OVERVIEW

  • Dry Eyes - A Lucrative Segment of Ophthalmology Market
    • Table 1: Global Ophthalmology Market (2017): Percentage Share Breakdown by Product Segment (includes corresponding Graph/Chart)
  • Artificial Tears: The First Line and Mainstay Treatment for Dry Eyes
    • Table 2: Global Dry Eye Treatment Market (2017): Percentage Share Breakdown of Revenues by Over-the-Counter and Rx Segments (includes corresponding Graph/Chart)
  • Other Therapies for Dry Eye
  • Current & Future Analysis
  • Developing Countries Display Strong Growth Prospects
  • Under-reporting of DES Condition Stifles Market Opportunities
  • Prevalence and Incidence of Dry Eye Syndrome
    • Table 3: Prevalence of Dry Eye Syndrome Across Select Countries (in %) (includes corresponding Graph/Chart)
  • Select Stats on Prevalence Rates
  • Concentrated Prescription Dry Eye Products Market Benefits OTC Market
  • Multi-Factorial Nature of Dry Eye Poses Challenges to Drug Makers
  • Aging Population - A Major Growth Driver
    • Table 4: Global Population Demographics (2017 & 2020P): Percentage Breakdown of Population by Age Group - Below 40 Years and 40 Years & Above (includes corresponding Graph/Chart)
  • Market Challenges
  • Lack of Clear Product Differentiation
  • Drug Formulation Fraught with Difficulties
  • Low Patient Compliance Limits Market Opportunities

3. NOTEWORTHY MARKET TRENDS

  • Companies Focus on New Formulations to Improve Results
  • Preference for Preservative-Free Artificial Tears on Rise
  • Management of Dry Eyes Post Eye Surgery Drives Demand for Artificial Tears
    • Table 5: Number of LASIK Surgeries in US and Europe (2015-2020) (in '000) (includes corresponding Graph/Chart)
  • Rise in Mobile Workforce and Number of Smartphone Addicts Spurs Growth Prospects
    • Table 6: Global Smartphone Adoption Rate (2013-2020) (includes corresponding Graph/Chart)
    • Table 7: Number of Mobile Phone Users Worldwide (2014-2020) (in Billions) (includes corresponding Graph/Chart)
  • An Upswing in Contact Lens Wearers Unfolds New Opportunities
    • Table 8: Penetration of Contact Lenses in Select Countries/Regions (2017) (includes corresponding Graph/Chart)
  • Manufacturers Focus Efforts on Formulating the Right Artificial Tears for Contact Lens Wearers
  • Environmental Factors Play an Important Role
  • Nanotechnology and Other Innovative Delivery Techniques Gain Attention in DES Treatment
  • Direct-to-Customer Promotions: A Primary Marketing Strategy

4. DRY EYE SYNDROME - AN OVERVIEW

  • Dry Eye - A Common Ophthalmic Condition
  • Causes of Dry Eyes
  • Diagnosis of Dry Eye Syndrome
  • Multi-Factorial Nature of Dry Eye Poses Challenge to Drug Makers
  • Bridging Chasm between Diagnosis and Treatment of Dry Eye Syndrome
  • Product Options for Dry Eye Syndrome: Breakdown by Palliative Therapies and Targeted Therapies
  • KCS Inflammation Cycle
  • Common Symptoms of KCS
  • Risk Factors for Dry Eye Disease
  • Impact of Dry Eye Syndrome on Routine Daily Life Activities: Ranking based on Intensity of Impact Felt by Patients
  • Novel Approaches to Revolutionize Dry Eye Therapy
  • Anti-Inflammatory Drugs
  • Mucin Secretagogues
  • Hormonal Therapies
  • Omega-3 Drugs
  • Muco-Mimetics
  • Barrier-function Drugs

5. PRODUCT OVERVIEW

  • Artificial Tears - An Overview
  • Types of Artificial Tears
  • Artificial Tears Usage and Dosage
  • Evolution of Artificial Tears
  • First-Generation
  • Second-Generation
  • Third-Generation
  • Fourth-Generation
  • Alternate Treatment Methods

6. COMPETITIVE LANDSCAPE

  • Leading Players
    • Table 9: Leading Players in the Global Artificial Tears Market (2016): Percentage Share Breakdown of Sales by Company (includes corresponding Graph/Chart)
  • Artificial Tears for Dry Eye Syndrome-Single-use (Unit dose)
  • Artificial Tears for Dry Eye Syndrome-Multi dose
  • 6.1 Focus on Select Global Players
  • Allergan plc (Ireland)
  • Akorn, Inc. (USA)
  • Bausch & Lomb Incorporated (USA)
  • Johnson & Johnson (USA)
  • Novartis International AG (Switzerland)
  • Alcon, Inc. (Switzerland)
  • Santen Pharmaceuticals Co, Ltd. (Japan)
  • 6.2 Product Launches/Approvals/Introductions
  • Alcon Launches Systane Complete
  • Grafton Optical Adds I-LID 'N LASH(r) Ocular Hygiene Product Line from I-MED Pharma
  • Allergan Introduces TrueTear (Allergan)
  • Novaliq Introduces NovaTears(r)
  • Allergan Launches REFRESH OPTIVE(r) MEGA-3
  • Thea Pharmaceuticals Introduces Thealoz Duo
  • 6.3 Recent Industry Activity
  • Novartis to Spinoff Alcon
  • I-MED Pharma Signs Distribution Agreement with IMEX
  • Novartis to In-license ECF843 for Ophthalmic Indications
  • Johnson & Johnson Acquires Abbott Medical Optics

7. GLOBAL MARKET PERSPECTIVE

    • Table 10: World Recent Past, Current & Future Analysis for Artificial Tears by Geographic Region/ Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 Through 2024 (includes corresponding Graph/Chart)
    • Table 11: World Historic Review for Artificial Tears by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 Through 2015 (includes corresponding Graph/Chart)
    • Table 12: World 14-Year Perspective for Artificial Tears by Geographic Region/Country - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)

8. REGIONAL MARKET PERSPECTIVE

  • 8.1 The United States
  • A. Market Analysis
    • Current and Future Analysis
    • Table 13: Prevalence of Dry Eye Disease in the US (2017): Percentage Breakdown by Dry Eye Category (includes corresponding Graph/Chart)
    • Demographics Remain an Important Growth Driver
    • Table 14: US Population Demographics (2015-2030): Percentage Breakdown of Population by Age Group (includes corresponding Graph/Chart)
    • Table 15: Prevalence of Dry Eye Condition in the US (2014) (includes corresponding Graph/Chart)
    • Table 16: US Women Population (2015-2030): Percentage Breakdown of Population by Age Group (includes corresponding Graph/Chart)
    • Lifestyle and Environmental Factors - A Major Reason Behind Rise in Eye Care Market
    • Air Pollution Bears Close Association with DES Risk
  • B. Market Analytics
    • Table 17: US Recent Past, Current & Future Analysis for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 Through 2024 (includes corresponding Graph/Chart)
    • Table 18: US Historic Review for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 Through 2015 (includes corresponding Graph/Chart)
  • 8.2 Canada
  • Market Analysis
    • Table 19: Canadian Recent Past, Current & Future Analysis for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 Through 2024 (includes corresponding Graph/Chart)
    • Table 20: Canadian Historic Review for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 Through 2015 (includes corresponding Graph/Chart)
  • 8.3 Japan
  • A. Market Analysis
    • Current and Future Analysis
  • B. Market Analytics
    • Table 21: Japanese Recent Past, Current & Future Analysis for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 Through 2024 (includes corresponding Graph/Chart)
    • Table 22: Japanese Historic Review for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 Through 2015 (includes corresponding Graph/Chart)
  • 8.4 Europe
  • A. Market Analysis
    • Current and Future Analysis
    • Market Overview
    • Overview of Select Markets
      • Germany
      • Italy
      • UK
      • Russia
  • B. Market Analytics
    • Table 23: European Recent Past, Current & Future Analysis for Artificial Tears by Geographic Region/Country - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 Through 2024 (includes corresponding Graph/Chart)
    • Table 24: European Historic Review for Artificial Tears by Geographic Region/Country - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 Through 2015 (includes corresponding Graph/Chart)
    • Table 25: European 14-Year Perspective for Artificial Tears by Geographic Region/Country - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)
  • 8.5 Asia-Pacific
  • A. Market Analysis
    • Current and Future Analysis
    • Focus on Select Regional Markets
      • Australia
      • China
      • India
  • B. Market Analytics
    • Table 26: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Tears by Geographic Region/Country - China, India, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 Through 2024 (includes corresponding Graph/Chart)
    • Table 27: Asia-Pacific Historic Review for Artificial Tears by Geographic Region/Country - China, India, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 Through 2015 (includes corresponding Graph/Chart)
    • Table 28: Asia-Pacific 14-Year Perspective for Artificial Tears by Geographic Region/Country - Percentage Breakdown of Dollar Sales for China, India, and Rest of Asia-Pacific Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)
  • 8.6 Latin America
  • A. Market Analysis
    • Current and Future Analysis
  • B. Market Analytics
    • Table 29: Latin American Recent Past, Current & Future Analysis for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 Through 2024 (includes corresponding Graph/Chart)
    • Table 30: Latin American Historic Review for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 Through 2015 (includes corresponding Graph/Chart)
  • 8.7 Rest of World
  • Market Analysis
    • Table 31: Rest of World Recent Past, Current & Future Analysis for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 Through 2024 (includes corresponding Graph/Chart)
    • Table 32: Rest of World Historic Review for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 Through 2015 (includes corresponding Graph/Chart)

9. COMPANY PROFILES Total Companies Profiled: 49 (including Divisions/Subsidiaries - 54) The United States (19) Canada (3) Japan (3) Europe (14) - France (1) - Germany (3) - The United Kingdom (3) - Italy (1) - Spain (1) - Rest of Europe (9) Asia-Pacific (Excluding Japan) (12) Middle East (1) Africa (2) ARTIFICIAL TEARS MCP-7743 CONTENTS

Back to Top
전화 문의
F A Q